Published 2002
| Version v1
Journal article
The role of bisphosphonates in breast cancer: Direct effects of bisphosphonates on breast cancer cells
Creators
- 1. Department of Oncology, Gastroenterology, Endocrinology, and Metabolism, St George's Hospital Medical School, Cranmer Terrace, London (United Kingdom)
Description
In addition to inhibiting bone resorption, bisphosphonates have also been shown to exhibit antitumour effects. In vitro, bisphosphonates inhibit proliferation and induce apoptosis in cultured human breast cancer cells. In addition, bisphosphonate treatment interferes with breast cancer cell adhesion to bone matrix, and inhibits cell migration and invasion. The combination of bisphosphonates with other anticancer drugs such as the taxoids markedly enhances these effects. These newly recognized direct actions of bisphosphonates on breast cancer cells indicate that these agents may have a greater role to play in treatment of patients suffering from cancers with a propensity to metastasize to bone
Availability note (English)
Available from http://dx.doi.org/10.1186/bcr412; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC138711Additional details
Identifiers
Publishing Information
- Journal Title
- Breast Cancer Research (Print)
- Journal Volume
- 4
- Journal Issue
- 1
- Journal Page Range
- p. 18-23
- ISSN
- 1465-5411
INIS
- Country of Publication
- United Kingdom
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 47007040
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ADHESION; ANTINEOPLASTIC DRUGS; APOPTOSIS; IN VITRO; MAMMARY GLANDS; NEOPLASMS; SKELETON
- Descriptors DEC
- BODY; DISEASES; DRUGS; GLANDS; ORGANS
Optional Information
- Copyright
- Copyright (c) 2002 BioMed Central Ltd
- Notes
- PMCID: PMC138711; PUBLISHER-ID: bcr412; PMID: 11879555; OAI: oai:pubmedcentral.nih.gov:138711